Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes

被引：0
作者：
Mark E. Hwang
Mark Mayeda
Maria Liz
Brenda Goode-Marshall
Lissette Gonzalez
Carl D. Elliston
Catherine S. Spina
Oscar A. Padilla
Sven Wenske
Israel Deutsch
机构：
[1] Columbia University Medical Center,Department of Radiation Oncology
[2] Columbia University Medical Center,Department of Urology
来源：
Radiation Oncology | / 14卷
关键词：
Prostate cancer; Stereotactic body radiotherapy; Rectal toxicity; SpaceOAR hydrogel; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
    Hwang, Mark E.
    Mayeda, Mark
    Liz, Maria
    Goode-Marshall, Brenda
    Gonzalez, Lissette
    Elliston, Carl D.
    Spina, Catherine S.
    Padilla, Oscar A.
    Wenske, Sven
    Deutsch, Israel
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [2] Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer
    Tsurugai, Yuichiro
    Takeda, Atsuya
    Sanuki, Naoko
    Aoki, Yousuke
    Kimura, Yuto
    Oku, Yohei
    Eriguchi, Tomohiro
    Yamanaka, Hiroyuki
    Machida, Maiko
    Matsushita, Tomohiko
    Saito, Shiro
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024,
  • [3] Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer
    Ung, M.
    Bossi, A.
    Abbassi, L.
    Vautier, J.
    Anthonipillai, V
    Cheve, M.
    Blanchard, P.
    CANCER RADIOTHERAPIE, 2021, 25 (03): : 237 - 241
  • [4] A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy
    Mark E Hwang
    Paul J Black
    Carl D Elliston
    Brian A Wolthuis
    Deborah R Smith
    Cheng-Chia Wu
    Sven Wenske
    Israel Deutsch
    Radiation Oncology, 13
  • [5] A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy
    Hwang, Mark E.
    Black, Paul J.
    Elliston, Carl D.
    Wolthuis, Brian A.
    Smith, Deborah R.
    Wu, Cheng-Chia
    Wenske, Sven
    Deutsch, Israel
    RADIATION ONCOLOGY, 2018, 13
  • [6] Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
    Ogita, Mami
    Yamashita, Hideomi
    Nozawa, Yuki
    Ozaki, Sho
    Sawayanagi, Subaru
    Ohta, Takeshi
    Nakagawa, Keiichi
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [7] Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
    Mami Ogita
    Hideomi Yamashita
    Yuki Nozawa
    Sho Ozaki
    Subaru Sawayanagi
    Takeshi Ohta
    Keiichi Nakagawa
    Radiation Oncology, 16
  • [8] Use, Complications, and Costs of Stereotactic Body Radiotherapy for Localized Prostate Cancer
    Halpern, Joshua A.
    Sedrakyan, Art
    Hsu, Wei-Chun
    Mao, Jialin
    Daskivich, Timothy J.
    Nguyen, Paul L.
    Golden, Encouse B.
    Kang, Josephine
    Hu, Jim C.
    CANCER, 2016, 122 (16) : 2496 - 2504
  • [9] Travel Distance and Stereotactic Body Radiotherapy for Localized Prostate Cancer
    Mahal, Brandon A.
    Chen, Yu-Wei
    Sethi, Roshan V.
    Padilla, Oscar A.
    Yang, David D.
    Chavez, Janice
    Muralidhar, Vinayak
    Hu, Jim C.
    Feng, Felix Y.
    Hoffman, Karen E.
    Martin, Neil E.
    Spratt, Daniel E.
    Yu, James B.
    Orio, Peter F., III
    Nguyen, Paul L.
    CANCER, 2018, 124 (06) : 1141 - 1149
  • [10] Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis
    De Cooman, Brecht
    Debacker, Tibaut
    Adams, Thomas
    Lamberts, Guy
    De Troyer, Bart
    Claessens, Marc
    De Kerf, Geert
    Mercier, Carole
    Dirix, Piet
    Ost, Piet
    RADIATION ONCOLOGY, 2025, 20 (01)
12345